Atlantic American Corp

Atlantic American Corp (AAME) Stock Analysis

$1.110

-0.020 (-1.77%)At close

Loading chart…
High
1.110
Open
1.095
VWAP
1.11
Volume
14.51K
Mkt Cap
35.09M
Low
1.095
Amount
16.03K
EV/EBITDA, TTM
0.00

Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products.

www.atlam.com

AI analysis of Atlantic American Corp (AAME)

Sell

Atlantic American Corp (AAME) is not a good buy right now due to significant financial and compliance challenges. The stock has a current price of 1.18, which is down 59.03% year-to-date, indicating a severe decline in value. Additionally, the RSI is at a very low 18.571, suggesting that the stock is oversold, but this is not a strong enough indicator to warrant a buy. The company has also received multiple compliance notices from Nasdaq for failing to file necessary reports, which raises concerns about its operational stability. The main risk is the ongoing compliance issue, which could further impact investor confidence and stock performance.

Valuation Metrics

The current forward P/E ratio for Atlantic American Corp (AAME) is 7.39, compared to its 5-year average forward P/E of 1.15.

Forward P/E

Strongly Overvalued
5Y Average P/E
1.15
Current P/E
7.39
Overvalued
3.79
Undervalued
-1.49

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for AAME

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AAME

$2.86

Scenario price

B

Base

Base · 50%AAME

$2.63

Scenario price

B

Bear

Bear · 25%AAME

$2.18

Scenario price

AAME FAQ — answered by Alphio AI

Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products. It operates in the Financials sector (LIFE INSURANCE industry).

Atlantic American Corp (AAME) is not a good buy right now due to significant financial and compliance challenges. The stock has a current price of 1.18, which is down 59.03% year-to-date, indicating a severe decline in value. Additionally, the RSI is at a very low 18.571, suggesting that the stock is oversold, but this is not a strong enough indicator to warrant a buy. The company has also received multiple compliance notices from Nasdaq for failing to file necessary reports, which raises concerns about its operational stability. The main risk is the ongoing compliance issue, which could further impact investor confidence and stock performance.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading